medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2016, Number 5

<< Back Next >>

Ann Hepatol 2016; 15 (5)

Effects of combined genes of CTLA4Ig and IDO in post-liver transplantation immune tolerance of rats

Wu Y, Yu Z, Gong J, Li M, Liu Y, Gong J

Language: English
References: 31
Page: 729-737
PDF size: 312.07 Kb.


ABSTRACT

Background and rationale for the study. Previous studies showed that CTLA4Ig and indoleamine 2,3-dioxygenase (IDO) genes played regulatory role in organ transplantation but failed to reach satisfactory effects. In this study, we constructed an adenovirus- mediated gene expressing CTLA4Ig–IDO and established rat liver transplantation models. Recipients were randomly divided into four groups of 10 rats each. During the operation, CTLA4Ig, IDO, and CTLA4Ig–IDO genes, as well as a blank plasmid, were infused into different rat groups via portal vein to determine their effects on inducing immune tolerance. Survival rate of recipients, histological changes of graft liver, post-transplantation liver function, and cytokine levels were observed at day 14 after operation. Results. Serum levels of alanine aminotransferase (ALT), aspartate transaminase (AST), and total bilirubin level (TBIL) in the CTLA4Ig-IDO group were lower than those in the other three groups at 14 days post-transplantation (P ‹ 0.05); mRNA and protein expressions of IL-2 and IFN-γ were higher in the control group, but lower in the CTLA4Ig-IDO group (P ‹ 0.05). By contrast, expressions of IL-4, TGF-b, IL-10, and T lymphocyte apoptosis were higher in the CTLA4Ig-IDO group than those in the other three groups (P ‹ 0.05). The CTLA4Ig-IDO group exhibited mild acute rejection and higher survival rate compared with the other groups (P ‹ 0.05). Conclusion. Compared with using CTLA4Ig or IDO alone, combined transfection of CTLA4Ig-IDO was more effective in inducing immune tolerance after liver transplantation.


REFERENCES

  1. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006; 43: 54-62.

  2. Knaak J, McVey M, Bazerbachi F, Goldaracena N, Spetzler V, Selzner N, Cattral M, et al. Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubation. Liver Transpl 2015; 21: 761-7.

  3. Schmitz V, Neumann UP, Fischer U, Langrehr J, Neuhaus P. Induction of long-term graft acceptance by a combination treatment of donor splenocytes and CTLA4Ig in a high responder rat liver transplantation model. Transpl Int 2005; 18: 1187-96.

  4. Yamada Y, Ochiai T, Boskovic S, Nadazdin O, Oura T, Schoenfeld D, Cappetta K, et al. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant 2014; 14:2704-12.

  5. Deppong CM, Bricker TL, Rannals BD, Van Rooijen N, Hsieh CS, Green JM. CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-β. J Immunol 2013; 191: 3082-9.

  6. Ljung K, Simonson OE, Felldin U, Wärdell E, Ibarra C, Antonsson L, Kumagai-Braesch M, et al. Costimulation blockade induces foxp3(+) regulatory T cells to human embryonic stem cells. Biores Open Access 2013; 2: 455-8.

  7. Jiang GP, Hu ZH, Zheng SS, Jia CK, Zhang AB, Wang WL. Adenovirus-mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation. World J Gastroenterol 2005; 11: 1065-9.

  8. Bour JH, Blueston JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002; 22: 1-7.

  9. Ye QX, Xu LH, Xu W, Fang JP. Influence of blocking B7/CD28 and CD40/CD154 co-stimulatory signals on immune function of sensitized mice. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2014; 22: 801-7.

  10. Luan X, Liao W, Lai X, He Y, Liu Y, Gong J, Li J. Dynamic Changes of Indoleamine 2, 3-Dioxygenase of Kupffer Cells in Rat Liver Transplant Rejection and Tolerance. Transplant Proc 2012; 44: 1045-7.

  11. Laurence JM, Wang C, Park ET, Buchanan A, Clouston A, Allen RD, Mccaughan GW, et al. Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection. Transplantation 2008; 85: 1357-61.

  12. Jiang T, Sun Y, Yin Z, Feng S, Sun L, Li Z. Research progress of indoleamine 2, 3-dioxygenase inhibitors. Future Med Chem 2015; 7: 185-201.

  13. Laurence JM, Wang CM, Zheng ML, Cunningham S, Earl J, Tay SS, Allen RD, et al. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adenoassociated virus vector does not prevent acute rejection. Liver Transpl 2009; 15: 233-41.

  14. Pree I, Bigenzahn S, Fuchs D, Koporc Z, Nierlich P, Winkler C, Brandacher G, et al. CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine- 2,3-dioxygenase.Transplantation 2007; 83: 663-7.

  15. Wu YK, Wang YB, Li M, Yang X, Gong J, Zhang W. Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer-cell activation. Exp Ther Med 2014; 8: 1777-82.

  16. Demetris AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, Heart J, et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25:658-63.

  17. Kita Y, Li XK, Nogimura H, Ida M, Kageyama Y, Ohi S, Suzuki K, et al. Prolonged graft survival induced by CTLA4IG gene transfection in rat lung allografting. Transplant Proc 2003; 35: 456-7.

  18. Yang Z, Wu X, Tsui TY, Hou Y, Luk JM, Fan ST. Long-term liver allograft survival induced by combined treatment with rAAV-hCTLA4Ig gene transfer and low-dose FK506. Transplantation 2003; 75: 303-8.

  19. Lu S, Yu Y, Gao Y, Li GQ, Wang XH. Immunological inhibition of transplanted liver allografts by adeno-associated virus vector encoding CTLA4Ig in rats. Hepatobiliary Pancreat Dis Int 2008; 7: 258-63.

  20. Rim YA, Yi H, Kim Y, Park N, Jung H, Kim J, Jung SM, et al. Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector. Sci Rep 2014; 4: e6935.

  21. Chen Y, Wang Y, Fu Z. T lymphocyte antigen 4-modified dendritic cell therapy for asthmatic mice guided by the CCR7 chemokine receptor. Int J Mol Sci 2014; 15: 15304-19.

  22. Vavrincova-Yaghi D, Seelen MA, Kema IP, Deelman LE, van der Heuvel MC, Breukelman H, Van den Eynde BJ, et al. Early Post-transplant Tryptophan Metabolism Predicts Long- Term Outcome of Human Kidney Transplantation. Transplantation 2015; e: 25651307.

  23. Andersen MH, Svane IM. Indoleamine 2, 3-dioxygenase vaccination. Oncoimmunology 2015; 4: e983770.

  24. Polyzos KA, Ovchinnikova O, Berg M, Baumgartner R, Agardh H, Pirault J, Gistera A, et al. Inhibition of indoleamine 2, 3- dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice. Cardiovasc Res 2015; 106: 295-302.

  25. Sun X, Gong ZJ, Wang ZW, Li T, Zhang JY, Sun HC, Liu S, et al. IDO-competent-DCs induced by IFN-γ attenuate acute rejection in rat liver transplantation. J Clin Immunol 2012; 32: 837-47.

  26. Hill M, Zagani R, Voisine C, Usal C, Anegon I. Nitric Oxide and Indoleamine 2,3-Dioxygenase Mediate CTLA4Ig-Induced Survival in Heart Allografts in Rats. Transplantation 2007; 84: 1060-3.

  27. 27 Xiao B, Liu B, Song Y, Yu Z, Guo S. Local cytotoxic T-lymphocyte- associated antigen-4 immunoglobulin inhibition of rejection response is dependent on indoleamine 2, 3-dioxygenase activities in the allograft. Transplant Proc 2014; 46: 3637-40.

  28. Mulley WR, Nikolic-Paterson DJ. Indoleamine 2, 3-dioxygenase in transplantation. Nephrology (Carlton) 2008; 13: 204-11.

  29. Beutelspacher SC, Pillai R, Watson MP, Tan PH, Tsang J, Mc- Clure MO, George AJ, et al. Function of indoleamine 2, 3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006; 36: 690-700.

  30. Chen Y, Chen J, Liu Z, Liang S, Luan X, Long F, Peng Y, et al. Relationship Between TH1/TH2 Cytokines and Immune Tolerance in Liver Transplantation in Rats. Transplant Proc 2008; 40: 2691-5.

  31. Zhang J, Miao Q, Yang Y, Xiao B, Liu B, Cao J, Hao XY, et al. Effect of combined OX40Ig and CTLA4Ig gene local transfer on allograft rejection and the underlying mechanisms. J Surg Res 2012; 178: 949-58.




2020     |     www.medigraphic.com